Pharmacological approaches to treating negative symptoms: a review of clinical trials.
about
Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment optionsA systematic review of physical activity policy recommendations and interventions for people with mental health problems in Sub-Saharan African countries.Negative symptoms in schizophrenia.Impact of negative symptoms on healthcare resource utilization and associated costs in adult outpatients with schizophrenia: a population-based study.Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia.Do negative symptoms of schizophrenia change over time? A meta-analysis of longitudinal data.Negative symptoms in schizophrenia: a study in a large clinical sample of patients using a novel automated method.Motivating factors and barriers towards exercise in severe mental illness: a systematic review and meta-analysis.Indian psychiatric society multicentric study: Correlates of prescription patterns of psychotropics in India.Negative Symptoms in Schizophrenia: Where We have been and Where We are Heading.Adapted cognitive-behavioural therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regression.Cash, choice, antipsychotic medication and the mental health nurse.Pharmacological treatment of negative symptoms in schizophrenia.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders.Long-term maintenance and effects of exercise in early psychosis.Conceptualization and treatment of negative symptoms in schizophrenia.Managing Negative Symptoms of Schizophrenia: How Far Have We Come?Chinese version of the Schizotypal Personality Questionnaire: Factor structure replication and invariance across sex.Clozapine augmentation with amisulpride.Exercise as an intervention for first-episode psychosis: a feasibility study.Are negative symptoms in schizophrenia a distinct therapeutic target?[The German research network for mental disorders].Predictors of remission during acute treatment of first-episode schizophrenia patients involuntarily hospitalized and treated with algorithm-based pharmacotherapy: Secondary analysis of an observational study.
P2860
Q22241447-196DE101-88EE-43F9-B96B-E47E998EFF04Q33617569-892C9341-845C-4D29-8E27-42E69199E695Q33820512-521CBBED-5E35-41E8-A30B-0EFEBDFFDD4EQ34109212-64B2C8B8-142A-46D5-89F6-5F74B8C703C5Q34822992-60D3E288-0D99-4971-A410-F177B35BF1CBQ35450483-E2CE039B-6313-4017-84AE-807A083EC984Q36081015-BA33EBB8-4C9C-448F-8278-41CAABC99B19Q37367096-5979FE43-A0E6-421D-B85D-CCCA328C00B6Q37609738-00BE7000-C6EC-4DD1-BA9B-FCDBBCC22ACFQ38220400-1254F01C-27DE-43B8-B96A-D4C65CC2F28CQ38226117-6E5A9024-2B48-44B3-BA22-ED4D45115A01Q38365551-1748A5F8-2E15-4ED3-9DB2-C44495E88311Q38431333-3A3B4266-803F-4EE3-BC80-DB733ED074DEQ38815462-2D558D5C-681F-4C5A-9292-D51EA8CC8425Q38825126-8FEE5F65-42F2-49BF-A1FC-B8805530BF2BQ39178474-5E559CEA-268C-4A08-9FDF-7434FDCDA8C4Q39233330-E115AAEC-FC3A-4FED-B102-43F5424211DDQ40462639-468BF152-E619-4EA1-A7C3-8C03436EC1B5Q42969381-C19320C7-2B5D-48B8-ADA6-41D60629F247Q48826860-C2F944C6-D3AF-4FE8-B3F9-9D1B982F6562Q49381903-9C441EE8-8EA5-4F68-B1DE-FDBC5D549967Q50302553-C0598A3A-32FC-43B0-869B-E5DB75E20EA0Q52677444-D01925E9-56CC-4552-8011-B0B1E7EE4C24
P2860
Pharmacological approaches to treating negative symptoms: a review of clinical trials.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacological approaches to treating negative symptoms: a review of clinical trials.
@en
type
label
Pharmacological approaches to treating negative symptoms: a review of clinical trials.
@en
prefLabel
Pharmacological approaches to treating negative symptoms: a review of clinical trials.
@en
P1476
Pharmacological approaches to treating negative symptoms: a review of clinical trials.
@en
P2093
George Garibaldi
Stephen R Marder
P304
P356
10.1016/J.SCHRES.2013.07.026
P407
P50
P577
2013-08-09T00:00:00Z